Revenue
2011
2012
2022
2023
2024
2025
TuHURA Biosciences, Inc. (HURA)
Price$2.04Cached quote
Net income
2011
2011
2012
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2022
2023
2023
2024
2024
2025
Free cash flow
2016
2017
2018
2019
2020
2021
2022
2022
2023
2023
2024
2024
2025
Total cash / debt
CashTotal debt
2011
2011
2012
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2022
2023
2023
2024
2024
2025
Financial statements
| 2025 | 2024 · Dec 31 | 2024 · Jun 30 | 2023 · Dec 31 | 2023 · Jun 30 | 2022 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 · Dec 31 | 2012 · Jun 30 | 2011 · Dec 31 | 2011 · Jun 30 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $0 | $0 | — | $0 | — | $0 | — | — | — | — | — | — | — | — | — | — | — | $0 | — | $0 |
| Research & development | $20.5M | $13.3M | $2.7M | $9.4M | $9.3M | $7.9M | $15.2M | $11.8M | $3.6M | $3.7M | $7.1M | $5.0M | $3.4M | $2.6M | $2.1M | $2.3M | $1.6M | — | $1.1M | — |
| Operating expenses | $31.8M | $17.6M | $8.5M | $29.8M | $14.8M | $9.7M | $22.7M | $38.2M | $9.2M | $8.4M | $11.2M | $8.3M | $6.2M | $4.7M | $5.3M | $6.3M | $2.7M | $18,885 | $1.3M | $33,136 |
| Operating income | −$27.3M | −$17.2M | — | −$13.2M | — | −$9.7M | — | — | — | — | — | — | — | — | — | — | — | −$18,885 | — | −$33,136 |
| EBITDA | −$29.4M | −$17.4M | — | −$29.1M | — | −$9.0M | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Net income | −$30.1M | −$21.7M | −$8.3M | −$29.3M | −$14.6M | −$9.4M | −$22.7M | −$38.3M | −$9.1M | −$8.0M | $11.1M | $8.1M | $8.9M | −$4.3M | $6.4M | −$8.3M | −$2.4M | −$18,885 | −$1.3M | −$33,136 |
| Basic EPSper basic share | -$0.63 | -$1.21 | -$0.32 | -$2.47 | -$9.27 | -$0.77 | -$25.80 | -$0.64 | -$0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | -$0.03 | -$0.04 | -$0.03 | $0.00 | -$0.02 | $0.00 |
| Diluted EPSper diluted share | -$0.63 | -$1.21 | — | -$2.47 | — | -$0.77 | — | — | — | — | — | — | — | $0.02 | $0.00 | -$0.04 | -$0.03 | $0.00 | -$0.02 | $0.00 |
Owners
Reported shareholders
≈12.56%of listed shares
Patel Vijay8M shares · Oct 18, 2024
View holders
| Holder | % owned |
|---|---|
Patel Vijay | ≈12.56%8M shares |
VANGUARD CAPITAL MANAGEMENT LLC | 3.56%2.27M shares |
Bianco James A. | ≈3.41%2.17M shares |
NORTHERN TRUST CORP | 2.55%1.62M shares |
BlackRock, Inc. | 1.08%690.09K shares |
GEODE CAPITAL MANAGEMENT, LLC | 0.76%484.22K shares |
MILLENNIUM MANAGEMENT LLC | 0.71%454.54K shares |
AQR CAPITAL MANAGEMENT LLC | 0.67%424.6K shares |
VANGUARD FIDUCIARY TRUST CO | 0.39%251.19K shares |
CITADEL ADVISORS LLC | 0.36%232.32K shares |
STATE STREET CORP | 0.30%188.4K shares |
JANE STREET GROUP, LLC | 0.26%163.89K shares |
Apollon Wealth Management, LLC | 0.25%156.52K shares |
Qube Research & Technologies Ltd | 0.23%145.6K shares |
MORGAN STANLEY | 0.22%143.26K shares |
GOLDMAN SACHS GROUP INC | 0.21%131.77K shares |
Bank of New York Mellon Corp | 0.19%121.66K shares |
XTX Topco Ltd | 0.16%100.42K shares |
WealthShield Partners, LLC | 0.14%91.53K shares |
Aster Capital Management (DIFC) Ltd | 0.14%89.69K shares |
Percentages use 63.68M shares of this listed class outstanding on Jun 30, 2026. ≈ compares the latest reported holding with a share total from a different date; it is not a confirmed current stake.
Gray completes the 100% scale. Reported positions may overlap; holders have different reporting dates.
Source: SEC Form 3 ↗Updated Sep 29, 2026 · Quarterly data